Drug Profile
Nexopamil
Alternative Names: LU 49938Latest Information Update: 22 Jan 2013
Price :
$50
*
At a glance
- Originator Abbott GmbH & Co. KG
- Class Antiarrhythmics; Antihypertensives; Ischaemic heart disorder therapies; Phenethylamines; Small molecules
- Mechanism of Action Calcium channel antagonists; Serotonin 5-HT2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Angina pectoris; Arrhythmias; Hypertension; Ischaemic heart disorders; Thrombosis